Sotera Health (SHC) Stock Price, News & Analysis

Company Overview

Sotera Health Company (NASDAQ: SHC) is a global provider of sterilization, laboratory testing and other healthcare services designed to support infection prevention and product safety. The company serves medical device, pharmaceutical and healthcare customers, helping them meet regulatory and quality requirements throughout the product life cycle.

Sotera Health operates through three primary businesses. Sterigenics provides contract sterilization and microbial reduction services for medical devices, pharmaceutical products, food and other products. Nelson Labs offers outsourced laboratory testing, including microbiological, analytical, environmental monitoring, packaging and other quality-control services. Nordion supplies medical isotopes, including cobalt-60, and related technologies used in sterilization and cancer treatment applications.

Through its network of facilities and laboratories, Sotera Health serves customers across North America, Europe, Asia and other international markets. The company’s businesses support the development, production and distribution of products used in healthcare and other regulated industries.

Key Stats

• Today's Range: $18.94 to $19.64
• 50-Day Range: $17.24 to $19.57
• 52-Week Range: $13.09 to $19.85
• Volume: 2.01 million shs
• Average Volume: 1.82 million shs
• Market Capitalization: $5.41 billion
• P/E Ratio: 33.25
• Dividend Yield: N/A
• Price Target: $21.50
• Consensus Rating: Moderate Buy

Sotera Health Stock Analysis - MarketRank™

Sotera Health scored higher than 79% of companies evaluated by MarketBeat, and ranked 156th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Sotera Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on no strong buy ratings, 8 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

Sotera Health has a consensus price target of $21.50, representing about 13.5% upside from its current price of $18.95.

Amount of Analyst Coverage

Sotera Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 9.30%

Earnings Growth

Earnings for Sotera Health are expected to grow by 9.30% in the coming year, from $0.86 to $0.94 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Sotera Health is 33.25, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.68.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sotera Health is 33.25, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.27.

Price to Book Value per Share Ratio

Sotera Health has a P/B Ratio of 8.90. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.95% of the float of Sotera Health has been sold short.

Short Interest Ratio / Days to Cover

Sotera Health has a short interest ratio ("days to cover") of 4.58.

Change versus previous month

Short interest in Sotera Health has recently decreased by 1.29%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Sotera Health does not currently pay a dividend.

Dividend Growth

Sotera Health does not have a long track record of dividend growth.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: 0.99

News Sentiment

Sotera Health has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Sotera Health this week, compared to 3 articles on an average week.

Search Interest

Only 1 people have searched for SHC on MarketBeat in the last 30 days. This is a decrease of -83% compared to the previous 30 days.

Company Ownership

• Score: 2.0 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Sotera Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $23,999,528.00 in company stock.

Percentage Held by Insiders

15.36% of the stock of Sotera Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

91.03% of the stock of Sotera Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/17/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:SHC
• CIK: 1822479
• Web: www.soterahealth.com
• Phone: 440-262-1410
• Fax: N/A
• Employees: 3,000
• Year Founded: 2017

Price Target and Rating

• Average Price Target for Sotera Health: $21.50
• High Price Target: $25.00
• Low Price Target: $18.00
• Potential Upside/Downside: +13.5%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.73
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.57
• Trailing P/E Ratio: 33.25
• Forward P/E Ratio: 22.03
• P/E Growth: N/A
• Net Income: $77.94 million
• Net Margins: 13.44%
• Pretax Margin: 21.72%
• Return on Equity: 40.12%
• Return on Assets: 7.55%

Debt

• Debt-to-Equity Ratio: 3.33
• Current Ratio: 2.80
• Quick Ratio: 2.55

Sales & Book Value

• Annual Sales: $1.16 billion
• Price / Sales: 4.65
• Cash Flow: $1.25 per share
• Price / Cash Flow: 15.13
• Book Value: $2.13 per share
• Price / Book: 8.90

Miscellaneous

• Outstanding Shares: 285,380,000
• Free Float: 241,541,000
• Market Cap: $5.41 billion
• Optionable: Optionable
• Beta: 1.77